Benutzer: Gast  Login
Dokumenttyp:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
Autor(en):
Götze, K; Platzbecker, U; Giagounidis, A; Haase, D; Lübbert, M; Aul, C; Ganser, A; Germing, U; Hofmann, WK
Titel:
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.
Abstract:
Myelodysplastic syndromes (MDS) are a group of common bone marrow disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and a substantial risk of progression to acute myeloid leukemia (AML). For many years, the main treatment option for MDS was best supportive care which alleviates symptoms, but has no effect on the natural course of the disease. Recently, demethylating agents have become available as a promising new treatment for patients with MDS. In two randomized clini...     »
Zeitschriftentitel:
Ann Hematol
Jahr:
2010
Band / Volume:
89
Heft / Issue:
9
Seitenangaben Beitrag:
841-50
Sprache:
eng
Volltext / DOI:
doi:10.1007/s00277-010-1015-0
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/20567826
Print-ISSN:
0939-5555
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX